MARVERTI, Gaetano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.785
EU - Europa 6.934
AS - Asia 6.667
SA - Sud America 1.061
Continente sconosciuto - Info sul continente non disponibili 271
AF - Africa 133
OC - Oceania 17
Totale 31.868
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.359
SG - Singapore 1.997
CN - Cina 1.829
GB - Regno Unito 1.825
IT - Italia 1.618
VN - Vietnam 828
BR - Brasile 812
DE - Germania 773
SE - Svezia 688
HK - Hong Kong 638
FR - Francia 404
RU - Federazione Russa 345
FI - Finlandia 306
BD - Bangladesh 272
PL - Polonia 221
UA - Ucraina 208
KR - Corea 207
CA - Canada 201
IN - India 187
TR - Turchia 142
ID - Indonesia 117
BG - Bulgaria 86
JP - Giappone 86
AR - Argentina 83
IQ - Iraq 72
IE - Irlanda 70
NL - Olanda 70
MX - Messico 68
LT - Lituania 63
BE - Belgio 58
ES - Italia 49
ZA - Sudafrica 45
AE - Emirati Arabi Uniti 38
CO - Colombia 38
PK - Pakistan 35
EC - Ecuador 31
VE - Venezuela 30
CZ - Repubblica Ceca 27
CL - Cile 26
CR - Costa Rica 26
MY - Malesia 26
CH - Svizzera 24
UZ - Uzbekistan 23
TT - Trinidad e Tobago 22
HN - Honduras 20
AT - Austria 19
KE - Kenya 19
GT - Guatemala 16
SA - Arabia Saudita 16
TW - Taiwan 16
NI - Nicaragua 15
NP - Nepal 15
PR - Porto Rico 15
PY - Paraguay 15
PH - Filippine 14
AU - Australia 13
JM - Giamaica 13
SV - El Salvador 13
EG - Egitto 12
UY - Uruguay 12
IL - Israele 11
MA - Marocco 11
AZ - Azerbaigian 10
CW - ???statistics.table.value.countryCode.CW??? 10
IR - Iran 10
JO - Giordania 10
RO - Romania 9
BY - Bielorussia 8
DK - Danimarca 8
GR - Grecia 8
DZ - Algeria 7
ET - Etiopia 7
GP - Guadalupe 7
PE - Perù 7
SY - Repubblica araba siriana 7
BO - Bolivia 6
KZ - Kazakistan 6
LK - Sri Lanka 6
PT - Portogallo 6
TN - Tunisia 6
BH - Bahrain 5
GE - Georgia 5
KG - Kirghizistan 5
LB - Libano 5
NO - Norvegia 5
SC - Seychelles 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
AL - Albania 4
DO - Repubblica Dominicana 4
EE - Estonia 4
EU - Europa 4
HU - Ungheria 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
OM - Oman 4
PS - Palestinian Territory 4
RS - Serbia 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
Totale 31.562
Salva come PNG Salva come JPEG
Città #
Ashburn 1.998
Santa Clara 1.281
Fairfield 1.253
Southend 1.185
Singapore 1.164
San Jose 842
Woodbridge 827
Chandler 796
Hong Kong 620
Hefei 585
Ann Arbor 540
Seattle 527
Houston 524
Council Bluffs 507
Cambridge 447
Wilmington 422
Nyköping 378
Jacksonville 376
Dearborn 359
Chicago 358
Los Angeles 337
Modena 308
Beijing 302
New York 278
London 266
Ho Chi Minh City 243
Frankfurt am Main 239
Helsinki 214
Hanoi 206
Seoul 186
Munich 180
Kraków 169
The Dalles 132
Salt Lake City 127
San Diego 120
Milan 106
Princeton 94
São Paulo 92
Bologna 91
Jakarta 88
Sofia 84
Buffalo 83
Dallas 81
Moscow 81
Lauterbourg 80
Eugene 79
Fremont 79
Orem 73
Porto Alegre 71
Izmir 70
Dublin 65
Boardman 64
Shanghai 64
Tampa 62
Tokyo 60
Phoenix 58
Toronto 57
Columbus 51
Atlanta 48
Elk Grove Village 47
Parma 47
Washington 47
Brussels 46
Denver 45
Rome 44
Redwood City 43
Warsaw 43
Da Nang 36
Lancaster 36
Des Moines 35
Montreal 34
Guangzhou 32
Miami 32
Chennai 31
Amsterdam 30
Brooklyn 30
Ottawa 29
Grafing 28
Sterling 28
Stockholm 28
Norwalk 27
Reggio Emilia 27
Haiphong 26
Bremen 25
Mexico City 23
Verona 23
Kent 22
Tashkent 22
Manchester 21
Baghdad 20
Dulles 20
Falls Church 20
North Bergen 20
San Francisco 20
San José 20
Turku 20
Belo Horizonte 19
Boston 19
Brasília 19
Brno 19
Totale 21.280
Salva come PNG Salva come JPEG
Nome #
N-1,N-12-bis(ethyl)spermine effect on growth of cis-diamminedichloroplatinum(II)-sensitive and -resistant human ovarian-carcinoma cell lines 514
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 509
Spermidine/spermine N1-acetyltranferasemodulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistanthuman ovarian cancer cell lines 494
Cisplatin-resistance modulates the effect of protein synthesis inhibitors on spermidine/spermine N-1-acetyltransferase expression 492
Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth 491
Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells 485
Spermidine/spermine N1-acetyltransferase transient over-expression restores sensitivity of resistant human ovarian cancer cells to N1,N12-bis(ethyl)spermine and to cisplatin 470
Synthesis, cytotoxic and combined cDDP activity of new stable curcumin derivatives 457
Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells. 457
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 442
Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth 435
1H, 13C, 195Pt NMR study on platinum(II) interaction with sulphur containing Amadori compounds 432
Polyamine depletion switches the form of 2-deoxy-D-ribose-induced cell death from apoptosis to necrosis in HL-60 cells. 429
Newly synthesized curcumin derivatives: crosstalk between chemico-physical properties and biological activity. 423
Internalization and stability of a thymidylate synthase peptide inhibitor in ovarian cancer cells 422
Intracellular quantitative detection of human thymidylate synthase engagement with an unconventional inhibitor using tetracysteine-diarsenical-probe technology 422
Studies on the anti-proliferative effects of novel DNA-intercalating bipyridyl-thiourea-Pt(II) complexes against cisplatin-sensitive and -resistant human ovarian cancer cells 420
Translational repression of thymidylate synthase by targeting its mRNA 416
Repurposing of drugs targeting yap-tead functions 412
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 409
Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells 397
Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance 397
Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies 397
Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and-resistant human ovarian cancer cells 395
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells 395
Mass Spectrometric/Bioinformatic Identification of a Protein Subset That Characterizes the Cellular Activity of Anticancer Peptides 394
Proteomic Approach to the Detection of the Mechanism of Action of Anticancer Peptides 393
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 391
Synthesis, chemical and biological studies on new Fe3þ-glycosilated b-diketo complexes for the treatment of iron deficiency 377
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 375
PTEROATE-PEPTIDE BIOCONJUGATE TARGETING THE FOLATE RECEPTOR IN HUMAN OVARIAN CANCER CELL LINES: TRANSPORT AND MECHANISM OF ACTION. 372
A proteomic approach to investigate the mechanism of action of anticancer peptides 369
The effect of spermine on calcium requirement for protein kinase C association with phospholipid vesicles. 367
Differential induction of spermidine/spermine N1-acetyltransferase activity in cisplatin-sensitive and -resistant ovarian cancer cells in response to N1,N12-bis (ethyl)spermine involves transcriptional and post-transcriptional regulation. 356
Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells 354
Polyamine depletion protects HL-60 cells from 2-deoxy-D-ribose-induced apoptosis. 350
ANTICANCER DRUGS 347
Modulation of cis-diamminedichloroplatinum(II) accumulation and cytotoxicity by spermine in sensitive and resistant human ovarian carcinoma cells. 341
Effect of Spermine on Membrane-Associated and Membrane-Inserted Forms of Protein Kinase C 335
Depletion of Trichoplein (TpMs) Causes Chromosome Mis-Segregation, DNA Damage and Chromosome Instability in Cancer Cells 335
The 1,10-phenanthroline ligand enhances the antiproliferative activity of dna-intercalating thiourea-pd(Ii) and-pt(ii) complexes against cisplatin-sensitive and-resistant human ovarian cancer cell lines 332
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer-US8916679 “B2 - Granted patent as second publication”. 329
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 329
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting 329
Designing selective Cys-ligands to unpair the binding of the Human Transcription Enhancer Associated Domain 4 (hTEAD-4) with its modulators to halt cancer cell growth 326
2-Deoxy-D-ribose-induced apoptosis in HL-60 cells is associated with the cell cycle progression by spermidine 322
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 317
Relationship Between Spermine and Calcium on the Activation Process of Protein Kinase C. 315
Spermine protects protein kinase C from phospholipid-induced inactivation 314
Effect of spermine on association of protein kinase C with phospholipid vesicles. 313
Ligand-Based Virtual Screening and ADME-Tox Guided Approach to Identify Triazolo-quinoxalines as Folate Cycle Inhibitors. 309
Chairperson EUTROC- Mayo Conference-Berlin - Preliminary characterization of pharmacodynamic biomarkers for LR-peptide growth inhibition of ovarian cancer (OC) cell models. 307
Collateral sensitivity to novel folate cycle inhibitors enhances cisplatin effectiveness against human ovarian cancer cells. 306
Invited lecture to 18th World Congress on Advances in Oncology and 16th International Symposium on Molecular Medicine 10-12 October, 2013, Creta Maris, Hersonissos, Crete, Greece 303
Heat shock protein 90 and serine/threonine kinase B-Raf inhibitors have overlapping chemical space 301
Inhibitor of Ovarian Cancer Cells growth by Virtual Screening: A New Thiazole Derivative Targeting Human Thymidylate Synthase 300
Erratum: Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase (Proceedings of the National Academy of Sciences of the United States of America (2011) 108, 34 (E542-E549) DOI: 10.1073/pnas.1104829108) 300
N-(naphthyl)-N′-(methoxy carbonyl)thiocarbamide and its Cu(I) complex: synthesis, spectroscopic, X-ray, DFT andin vitrocytotoxicity study 296
Synthesis, molecular structure exploration and in vitro cytotoxicity screening of five novel N, N′- disubstituted thiocarbamide derivatives 289
Development of new metal-chelating multi target drus derived from Curcumin 285
Transcriptional activation and cell cycle block are the keys for 5-fluorouracil induced up-regulation of human thymidylate synthase expression 275
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer 275
Folate Receptor Expression and Folate Receptor Targeted Chemotherapy in Cisplatin-sensitive and – resistant Human cancer cell lines Marverti G.a, Pirondi S.a, MarracciniC.a, Frassineti C.a, Helleman J.b, Berns E.M.J.J. b, and Costi, M.P. cThe 4th International Symposium on Folate Receptors and Transporters Cozumel, Mexico October 7 - 11, 2012 268
design, synthesis and biological evaluation of novel YAP:TEAD complex disruptors for thetreatment of colorectal cancer 262
Copper (I) complexes based on novel N, N'-disubstituted thiocarbamides: Synthesis, spectroscopic, in vitro cytotoxicity, DNA damage and G0/G1 cell cycle arrest studies 262
Development of a novel class of YAP:TEAD interface-3 molecular disruptors to treat colorectal carcinoma 256
A toolbox of biophysical and analytical assays helps to confirm the activity of novel hTS dimer disrupters (Ddis) with anticancer properties 256
Monodentate Coordination of N, N′-Disubstituted Thiocarbamide Ligands: Syntheses, Structural Analyses, In Vitro Cytotoxicity and DNA Damage Studies of Cu(I) Complexes 255
Glucosyl curcuminoid derivatives: Fe(III) and Ga(III) chelating agents with anti-cancer properties 253
Exploring the biological activity of a library of 1,2,5-Oxadiazole derivatives endowed with antiproliferative activity 253
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 249
Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library 248
Copper (I) complexes of N-(2/4 methoxy/2-chloro-4-nitro) phenyl-N’ (methoxycarbonyl) thiocarbamides as potential anticancer agents: Synthesis, crystal structure, in vitro cytotoxicity and DNA damage studies. 245
Effect of spermine on irreversible insertion of protein kinase C into phospholipid vesicles. 244
SSAT modulation by putative regulators of folate cycle enzymes expression in cisplatin-sensitive and –resistant human ovarian cancer cell lines. 244
LC-MS serum proteomics reveals a panel of proteins prognostic of positive responsiveness to bevacizumab therapy in late-stages ovarian cancer patients 239
Lead optimization of human thymidylate synthase dimer disrupters: from computational studies to evaluation of their biological profiles 237
Synthesis, characterization, Hirshfeld surface, cytotoxicity, DNA damage and cell cycle arrest studies of N, N-diphenyl-N'-(biphenyl-4- carbonyl/4-chlorobenzoyl) thiocarbamides 229
Stimulation of cis-diamminedichloroplatinum(II) accumulation by modulation of passive permeability with genistein: an altered responce in accumulation-defective resistant cells. 228
Targeting the dimer-monomer equilibrium of thymidylate synthase, to accelerate protein degradation and cancer cell growth inhibition 227
Enhanced anticancer effect of thymidylate synthase dimer disrupters by promoting intracellular accumulation 227
Experimental and theoretical exploration of molecular structure and anticancer properties of two N, N′–disubstituted thiocarbamide derivatives 226
Glucosyl curcuminoid derivatives: Fe(III) and Ga(III) chelating agents with anti-cancer properties 221
Effetto delle poliammine sulla regolazione della proteina cinasi C. 220
Telomere Dysfunction Is Associated with Altered {DNA} Organization in Trichoplein/Tchp/Mitostatin ({TpMs}) Depleted Cells 218
Structural bases for the synergistic inhibition of human thymidylate synthase and ovarian cancer cell growth by drug combinations 217
Differential induction of spermidine/spermine N1-acetyltransferase in cisplatin-sensitive and -resistant human breast cancer cells by N1, N12-bis(ethyl)spermine. 212
Precision medicine through proteomics studies in drug resistant colorectal cancer 210
Lead-optimization process and characterization of the dissociative effect applied to new dimer disrupters of human Thymidylate Synthase 207
Integrating MS proteomics in the Medicinal Chemistry pipeline as powerful tool to overcome drug resistance issues in colorectal cancer 206
Development of a sensitive biochemical tool to assess the expression levels of recombinant ectopic proteins in in vitro engineered cellular systems 204
Inhibition of cell growth by accumulated spermine is associated with a transient alteration of cell cycle progression 198
Synthesis, spectroscopic, crystal structure and in vitro cytotoxicity studies of N-thiophenoyl-N'-substituted phenyl thiocarbamide derivatives 196
Cellular uptake and metabolic degradation of a conjugate of folic acid with an anticancer peptide targeting the human Thymidylate synthase enzyme 192
Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy 190
Dabrafenib-Panobinostat Salt: Improving Dissolution Rate and Inhibition of BRAF Melanoma Cells 175
MS Proteomics And Biochemical Characterization Of Thymidylate Synthase Dimer Destabilizer E7 To Halt Colorectal Carcinoma 165
Structural, Hirshfeld surface and in vitro cytotoxicity evaluation of five new N-aryl-N’-alkoxycarbonyl thiocarbamide derivatives. 165
Synthesis, characterisation, Hirshfeld surface and in vitro cytotoxicity evaluation of new N-aryl-N0-Alkoxycarbonyl thiocarbamide derivatives. 160
Structural insight into YAP-TEAD4 protein-protein interactions as target for cancer treatment 137
Totale 31.641
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.411
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.469 0 0 0 0 100 206 72 90 230 146 402 223
2022/20232.197 239 284 165 235 228 278 82 250 237 32 91 76
2023/20241.790 61 122 119 107 525 202 73 121 31 48 193 188
2024/20254.966 164 49 145 318 923 739 370 319 516 204 566 653
2025/20269.781 671 377 637 1.302 1.944 578 1.191 433 854 896 511 387
2026/20272.536 252 511 645 1.009 119 0 0 0 0 0 0 0
Totale 31.868